With the ongoing pandemic COVID-19, WHO has confirmed 3 018 681 cases worldwide . COVID-19 manifests with a wide clinical spectrum ranging from asymptomatic patients to septic shock and multiorgan dysfunction. Hence bringing COVID-10 to a terminal point has been a major challenge for researchers and clinicians. We have thus taken this opportunity to project and highlight articles on COVID-19 conveying our interest in both drug and vaccine discovery. Articles may range from original, reviews, mini reviews, case studies, perspectives and opinion articles.
In order to make the COVID-19 related information available on early basis, we will ensure authors a fast track peer reviewing for articles submitted under this special issue to value the present situation in favor of scientists. But authors must ensure that the article has been prepared by taking the guidelines of journal in consideration. Refer Guidelines for Authors on journal website.
If you are taking other drugs or supplements at the same time with the reception of the drug, the effectiveness of Ambien may change. Tell your doctor about all drugs, vitamins, and dietary supplements that you take. Your doctor will be able to make a proper plan for taking the drug, which will avoid negative interaction. Ambien may interact with the following drugs and products. More information about Ambien (Zolpidem) interaction on website https://tysonmutrux.com/ambien-zolpidem/.
Special Issue Editor for this topic will be Dr. Rohit Gundamaraju, University of Tasmania, Australia.
Authors are encouraged to submit their manuscript along with cover letter at below mentioned email id. Don’t forget to mention the Special Issue code in the cover letter.
Dr. Rajeev K. Singla
Founder and Editor-in-Chief
Indo Global Journal of Pharmaceutical Sciences
1. WHO Coronavirus disease (COVID-2019) situation reports. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200429-sitrep-100-covid-19.pdf?sfvrsn=bbfbf3d1_6 Accessed on 30.04.2020